A novel approach for combining the metagenome, metaresistome, metareplicome and causal inference to determine the microbes and their antibiotic resistance gene repertoire that contribute to dysbiosis. Issue 12 (20th December 2022)

• Record Type: Journal Article
• Authors: Stebliankin, Vitalii; Sazal, Musfiqur; Valdes, Camilo; Mathee, Kalai; Narasimhan, Giri
• Is Part Of: Microbial genomics. Volume 8:Issue 12(2022)
• Publication Date: 2022-12-20
• Subjects: antibacterial resistance -- causal Bayesian network -- multi-omics -- origin of replication -- peak-to-trough ratio (PTR); Microbial genomics -- Periodicals; 572.8629
• DOI: 10.1099/mgen.0.000899
• Languages: English
• ISSNs: 2057-5858

Abstract

Abstract : The use of whole metagenomic data to infer the relative abundance of all its microbes is well established. The same data can be used to determine the replication rate of all eubacterial taxa with circular chromosomes. Despite their availability, the replication rate profiles (metareplicome) have not been fully exploited in microbiome analyses. Another relatively new approach is the application of causal inferencing to analyse microbiome data that goes beyond correlational studies. A novel scalable pipeline called MeRRCI (Metagenome, metaResistome, and metaReplicome for Causal Inferencing) was developed. MeRRCI combines efficient computation of the metagenome (bacterial relative abundance), metaresistome (antimicrobial gene abundance) and metareplicome (replication rates), and integrates environmental variables (metadata) for causality analysis using Bayesian networks. MeRRCI was applied to an infant gut microbiome data set to investigate the microbial community's response to antibiotics. Our analysis suggests that the current treatment stratagem contributes to preterm infant gut dysbiosis, allowing a proliferation of pathobionts. The study highlights the specific antibacterial resistance genes that may contribute to exponential cell division in the presence of antibiotics for various pathogens, namely Klebsiella pneumoniae, Citrobacter freundii, Staphylococcus epidermidis, Veilonella parvula and Clostridium perfringens . These organisms often contribute to the harmful long-term sequelae seen in these young infants.